-
-
-
-
-
-
-
Prenetics reports Q1 2026 revenue of $36 million as IM8 business accelerates
-
-
-
-
-
-
-
Prenetics executives purchase $1.3 million in company stock
-
-
-
-
-
-
-
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
-
-
-
-
-
-
-
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
-
-
-
-
-
-
-
Prenetics Announces First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology
-
-
-
-
-
-
-
PartnerRe (PRE) Reports Q2 Loss of $2.91/sh
-
1,222,158 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

